Abstract
Bicyclic tetrapeptide hydroxamic acids were prepared as histone deacetylase (HDAC) inhibitors, and the evaluated inhibitory activity shows that they are potent against HDAC1 and HDAC4. The in vivo activity depends on alkyl loop length.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
MeSH terms
-
Bridged Bicyclo Compounds / chemical synthesis
-
Bridged Bicyclo Compounds / metabolism
-
Bridged Bicyclo Compounds / pharmacology
-
Histone Deacetylase Inhibitors / chemical synthesis*
-
Histone Deacetylase Inhibitors / metabolism
-
Histone Deacetylase Inhibitors / pharmacology
-
Histone Deacetylases / chemistry
-
Histone Deacetylases / metabolism*
-
Hydroxamic Acids / chemical synthesis*
-
Hydroxamic Acids / metabolism
-
Hydroxamic Acids / pharmacology
-
Oligopeptides / chemical synthesis*
-
Oligopeptides / metabolism
-
Oligopeptides / pharmacology
Substances
-
Bridged Bicyclo Compounds
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
Oligopeptides
-
Histone Deacetylases